Search research articles
Contact Us
Filters
Showing results (101-110 of 185) with videos related to
Page
of 19
Sort By:
Cancer Research
|
July 19, 2005
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate
Sorin Armeanu, Michael Bitzer, Ulrich M Lauer, et al.
Trials
|
July 12, 2020
Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial
Siri Göpel, Wolfgang Bethge, Peter Martus, et al.
The Journal of Biological Chemistry
|
May 22, 2002
Caspase-8 and Apaf-1-independent caspase-9 activation in Sendai virus-infected cells
Michael Bitzer, Sorin Armeanu, Florian Prinz, et al.
Frontiers in Oncology
|
February 27, 2024
Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)
Susanne Jung, Richard F Schlenk, Christopher Hackenbruch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 25, 2003
Negative-strand RNA viral vectors: intravenous application of Sendai virus vectors for the systemic delivery of therapeutic genes
Michael Bitzer, Guy Ungerechts, Sascha Bossow, et al.
The Journal of Nutritional Biochemistry
|
November 20, 2012
Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases
Alexander Berger, Sascha Venturelli, Mascha Kallnischkies, et al.
Zeitschrift Fur Gastroenterologie
|
January 9, 2024
Sabrina Groß, Michael Bitzer, Susanne Blödt, et al.
Frontiers in Immunology
|
March 25, 2026
Dysregulated NK-cell gene expression defines the enduring symptoms of long COVID-19
Urvi Ray, Antje Schulze Selting, Roshan Priyarangana Perera, et al.
Frontiers in Oncology
|
April 22, 2025
Case Report: FGFR2 inhibitor resistance via <i>PIK3CA</i> and <i>CDKN2A/B</i> in an intrahepatic cholangiocarcinoma patient with <i>FGFR2-SH3GLB1</i> fusion
Nadja Ballin, Alexander Ott, Olga Seibel-Kelemen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2018
Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis
Ulrich M Lauer, Martina Schell, Julia Beil, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 185) with videos related to
Sort By:
Page
of 19
Cancer Research
|
July 19, 2005
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate
Sorin Armeanu, Michael Bitzer, Ulrich M Lauer, et al.
Trials
|
July 12, 2020
Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial
Siri Göpel, Wolfgang Bethge, Peter Martus, et al.
The Journal of Biological Chemistry
|
May 22, 2002
Caspase-8 and Apaf-1-independent caspase-9 activation in Sendai virus-infected cells
Michael Bitzer, Sorin Armeanu, Florian Prinz, et al.
Frontiers in Oncology
|
February 27, 2024
Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)
Susanne Jung, Richard F Schlenk, Christopher Hackenbruch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 25, 2003
Negative-strand RNA viral vectors: intravenous application of Sendai virus vectors for the systemic delivery of therapeutic genes
Michael Bitzer, Guy Ungerechts, Sascha Bossow, et al.
The Journal of Nutritional Biochemistry
|
November 20, 2012
Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases
Alexander Berger, Sascha Venturelli, Mascha Kallnischkies, et al.
Zeitschrift Fur Gastroenterologie
|
January 9, 2024
Sabrina Groß, Michael Bitzer, Susanne Blödt, et al.
Frontiers in Immunology
|
March 25, 2026
Dysregulated NK-cell gene expression defines the enduring symptoms of long COVID-19
Urvi Ray, Antje Schulze Selting, Roshan Priyarangana Perera, et al.
Frontiers in Oncology
|
April 22, 2025
Case Report: FGFR2 inhibitor resistance via <i>PIK3CA</i> and <i>CDKN2A/B</i> in an intrahepatic cholangiocarcinoma patient with <i>FGFR2-SH3GLB1</i> fusion
Nadja Ballin, Alexander Ott, Olga Seibel-Kelemen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2018
Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis
Ulrich M Lauer, Martina Schell, Julia Beil, et al.
Page
of 19